Egetis Therapeutics AB

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -25.14% vs 2.87% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 21.05% vs -45.27% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.40",
          "val2": "17.90",
          "chgp": "-25.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-90.80",
          "val2": "-124.10",
          "chgp": "26.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.30",
          "val2": "4.60",
          "chgp": "36.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "1.40",
          "chgp": "-64.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-94.50",
          "val2": "-119.70",
          "chgp": "21.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,776.10%",
          "val2": "-6,933.00%",
          "chgp": "15.69%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 35.36% vs -19.97% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.32% vs -5.11% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.40",
          "val2": "46.10",
          "chgp": "35.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-343.20",
          "val2": "-323.50",
          "chgp": "-6.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.40",
          "val2": "17.60",
          "chgp": "-18.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.40",
          "val2": "-4.50",
          "chgp": "264.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-342.50",
          "val2": "-343.60",
          "chgp": "0.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,559.30%",
          "val2": "-7,093.30%",
          "chgp": "153.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

13.40

17.90

-25.14%

Operating Profit (PBDIT) excl Other Income

-90.80

-124.10

26.83%

Interest

6.30

4.60

36.96%

Exceptional Items

0.50

1.40

-64.29%

Consolidate Net Profit

-94.50

-119.70

21.05%

Operating Profit Margin (Excl OI)

-6,776.10%

-6,933.00%

15.69%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -25.14% vs 2.87% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 21.05% vs -45.27% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

62.40

46.10

35.36%

Operating Profit (PBDIT) excl Other Income

-343.20

-323.50

-6.09%

Interest

14.40

17.60

-18.18%

Exceptional Items

7.40

-4.50

264.44%

Consolidate Net Profit

-342.50

-343.60

0.32%

Operating Profit Margin (Excl OI)

-5,559.30%

-7,093.30%

153.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 35.36% vs -19.97% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 0.32% vs -5.11% in Dec 2024

All Annual Results